Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-09-29 4:33 pm Purchase |
2023-09-28 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 9,924,390 8.100% |
9,924,390![]() (New Position) |
Filing History |
2023-09-18 4:24 pm Purchase |
2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 3,727,952 5.600% |
3,727,952![]() (New Position) |
Filing History |
2023-09-15 5:11 pm Purchase |
2023-09-14 | 13G | Cybin Inc. CYBN |
Point72 Asset Management, L.P. | 498,684 8.100% |
498,684![]() (New Position) |
Filing History |
2023-07-27 4:20 pm Purchase |
2023-07-25 | 13G | Turnstone Biologics Corp. TSBX |
Point72 Asset Management, L.P. | 1,383,314 6.200% |
1,383,314![]() (New Position) |
Filing History |
2023-07-27 4:15 pm Purchase |
2023-07-26 | 13G | Health Catalyst, Inc. HCAT |
Point72 Asset Management, L.P. | 2,824,930 5.000% |
904,677![]() (+47.11%) |
Filing History |
2023-07-20 4:54 pm Purchase |
2023-07-19 | 13G | Chewy, Inc. CHWY |
Point72 Asset Management, L.P. | 6,705,883 5.800% |
6,705,883![]() (New Position) |
Filing History |
2023-07-20 4:15 pm Purchase |
2023-07-18 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management, L.P. | 4,085,544 5.100% |
4,085,544![]() (New Position) |
Filing History |
2023-06-26 4:30 pm Purchase |
2023-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX |
Point72 Asset Management, L.P. | 761,834 8.900% |
687,889![]() (+930.26%) |
Filing History |
2023-06-01 5:00 pm Purchase |
2023-05-31 | 13G | Cogent Biosciences, Inc. COGT |
Point72 Asset Management, L.P. | 3,562,902 5.000% |
3,562,902![]() (New Position) |
Filing History |
2023-05-24 5:15 pm Purchase |
2023-05-17 | 13G | Elevation Oncology, Inc. ELEV |
Point72 Asset Management, L.P. | 2,121,170 8.700% |
2,121,170![]() (New Position) |
Filing History |
2023-05-16 4:02 pm Purchase |
2023-05-15 | 13G | CUTERA INC CUTRQ |
Point72 Asset Management, L.P. | 1,144,407 5.800% |
1,144,407![]() (New Position) |
Filing History |
2023-04-05 4:23 pm Purchase |
2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 4,533,756 5.000% |
2,095,618![]() (+85.95%) |
Filing History |
2023-03-09 4:17 pm Purchase |
2022-12-31 | 13G | Cepton, Inc. CPTN |
Point72 Asset Management, L.P. | 181,523 1.200% |
181,523![]() (New Position) |
Filing History |
2023-02-23 7:43 pm Purchase |
2023-02-22 | 13G | Inari Medical, Inc. NARI |
Point72 Asset Management, L.P. | 2,795,352 5.200% |
2,795,352![]() (New Position) |
Filing History |
2023-02-17 4:35 pm Purchase |
2023-02-16 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Point72 Asset Management, L.P. | 8,114,890 5.000% |
8,114,890![]() (New Position) |
Filing History |
2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management, L.P. | 3,114,107 6.700% |
1,131,546![]() (+57.07%) |
Filing History |
2023-02-14 4:25 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,515,356 7.100% |
116,695![]() (+3.43%) |
Filing History |
2023-02-14 4:23 pm Purchase |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Point72 Asset Management, L.P. | 7,702,831 9.200% |
1,094,273![]() (+16.56%) |
Filing History |
2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 193,400 5.400% |
-22,502![]() (-10.42%) |
Filing History |
2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 6,281,645 6.700% |
1,615,538![]() (+34.62%) |
Filing History |